Literature DB >> 12507768

Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA.

Carsten G K Lüder1, Christine Lang, Mario Giraldo-Velasquez, Michaela Algner, Jens Gerdes, Uwe Gross.   

Abstract

Major histocompatibility complex (MHC) class II expression by microglia and astrocytes is critical for CD4+-mediated immune responses within the central nervous system. Here, we demonstrate that the obligate intracellular parasite, Toxoplasma gondii, down-regulates activation-induced MHC class II expression in human-derived glioblastoma cells as well as in primary astrocytes and microglia from cortices of rat fetuses. Down-regulation of MHC class II proteins was predominantly observed in parasite-positive, but not parasite-negative, host cells of T. gondii-infected cell cultures. MHC class II transcript levels induced by IFN-gamma alone or in combination with TNF-alpha were also clearly diminished after parasitic infection. Furthermore, T. gondii dose-dependently down-regulated the transcript levels of the class II transactivator CIITA. These results suggest that T. gondii partially evade CD4+-mediated intracerebral immune responses, a mechanism which may contribute to long-term persistence of the parasite within the CNS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507768     DOI: 10.1016/s0165-5728(02)00320-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  33 in total

1.  The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden.

Authors:  Harshita Satija Grover; Nicolas Blanchard; Federico Gonzalez; Shiao Chan; Ellen A Robey; Nilabh Shastri
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 2.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 3.  Subversion of innate and adaptive immune responses by Toxoplasma gondii.

Authors:  Christine Lang; Uwe Gross; Carsten G K Lüder
Journal:  Parasitol Res       Date:  2006-10-06       Impact factor: 2.289

4.  IL-4 independent nuclear translocalization of STAT6 in HeLa cells by entry of Toxoplasma gondii.

Authors:  Hye-Jin Ahn; Ji Yeon Kim; Ho-Woo Nam
Journal:  Korean J Parasitol       Date:  2009-05-27       Impact factor: 1.341

5.  Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.

Authors:  Florence Dzierszinski; Marion Pepper; Jason S Stumhofer; David F LaRosa; Emma H Wilson; Laurence A Turka; Sandra K Halonen; Christopher A Hunter; David S Roos
Journal:  Infect Immun       Date:  2007-09-10       Impact factor: 3.441

6.  The functional importance of sequence versus expression variability of MHC alleles in parasite resistance.

Authors:  Jan Axtner; Simone Sommer
Journal:  Genetica       Date:  2012-11-24       Impact factor: 1.082

Review 7.  Cell type- and species-specific host responses to Toxoplasma gondii and its near relatives.

Authors:  Zhee S Wong; Sarah L Sokol Borrelli; Carolyn C Coyne; Jon P Boyle
Journal:  Int J Parasitol       Date:  2020-05-11       Impact factor: 3.981

Review 8.  Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis.

Authors:  Hany M Elsheikha; Christina M Marra; Xing-Quan Zhu
Journal:  Clin Microbiol Rev       Date:  2020-11-25       Impact factor: 26.132

9.  Edmonston measles virus prevents increased cell surface expression of peptide-loaded major histocompatibility complex class II proteins in human peripheral monocytes.

Authors:  Mamadi Yilla; Carole Hickman; Marcia McGrew; Elizabeth Meade; William J Bellini
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Screening for Toxoplasma gondii-regulated transcriptional responses in lipopolysaccharide-activated macrophages.

Authors:  Chiang W Lee; Soumaya Bennouna; Eric Y Denkers
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.